Shearman Reps Boston Sci In $2B Unit Sale To Stryker
Stryker Corp. has agreed to buy Boston Scientific Corp.'s neurovascular business for $1.5 billion in cash in a move to become a leader in the $900 million market for medical devices...To view the full article, register now.
Already a subscriber? Click here to view full article